Ventricular Septal Defects Differential Diagnoses
- Author: Prema Ramaswamy, MD; Chief Editor: Stuart Berger, MD more...
Diagnostic Considerations
In addition to the conditions listed in the differential diagnosis of ventricular septal defect (VSD), other problems to be considered include the following:
- VSD with associated defects
- Atrioventricular (AV) septal defect
- Double-outlet right ventricle (RV) with normally related great arteries
- Mild or moderate subaortic stenosis
Differential Diagnoses
Roger H. Clinical researches on the congenital communication of the two sides of the heart by failure of occlusion of the interventricular septum. Bull de l' Acad de Med. 1879;8:1074.
Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J. Sep 27 1958;755-62. [Medline].
Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation. Oct 1958;18(4 Part 1):533-47. [Medline].
Van Praagh R, Geva T, Kreutzer J. Ventricular septal defects: how shall we describe, name and classify them?. J Am Coll Cardiol. Nov 1 1989;14(5):1298-9. [Medline].
Kidd L, Driscoll DJ, Gersony WM, et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation. Feb 1993;87(2 Suppl):I38-51. [Medline].
Wu MH, Wu JM, Chang CI, et al. Implication of aneurysmal transformation in isolated perimembranous ventricular septal defect. Am J Cardiol. Sep 1 1993;72(7):596-601. [Medline].
Wu MH, Wang JK, Lin MT, et al. Ventricular septal defect with secondary left ventricular-to-right atrial shunt is associated with a higher risk for infective endocarditis and a lower late chance of closure. Pediatrics. Feb 2006;117(2):e262-7. [Medline].
Rubin JD, Ferencz C, Loffredo C. Use of prescription and non-prescription drugs in pregnancy. The Baltimore-Washington Infant Study Group. J Clin Epidemiol. Jun 1993;46(6):581-9. [Medline].
Roguin N, Du ZD, Barak M, Nasser N, Hershkowitz S, Milgram E. High prevalence of muscular ventricular septal defect in neonates. J Am Coll Cardiol. Nov 15 1995;26(6):1545-8. [Medline].
Corone P, Doyon F, Gaudeau S, et al. Natural history of ventricular septal defect. A study involving 790 cases. Circulation. Jun 1977;55(6):908-15. [Medline].
Pongiglione G, Freedom RM, Cook D, Rowe RD. Mechanism of acquired right ventricular outflow tract obstruction in patients with ventricular septal defect: an angiocardiographic study. Am J Cardiol. Oct 1982;50(4):776-80. [Medline].
Zielinsky P, Rossi M, Haertel JC, et al. Subaortic fibrous ridge and ventricular septal defect: role of septal malalignment. Circulation. Jun 1987;75(6):1124-9. [Medline].
Muller WH, Danimann JF. The treatment of certain congenital malformations of the heart by the creation of pulmonic stenosis to reduce pulmonary hypertension and excessive pulmonary blood flow; a preliminary report. Surg Gynecol Obstet. Aug 1952;95(2):213-9. [Medline].
Lillehei CW, Cohen M, Warden HE. The results of direct vision closure of ventricular septal defects in eight patients by means of controlled cross circulation. Surg Gynecol Obstet. Oct 1955;101(4):446-66. [Medline].
Barratt-Boyes BG, Neutze JM, Clarkson PM, et al. Repair of ventricular septal defect in the first two years of life using profound hypothermia-circulatory arrest techniques. Ann Surg. Sep 1976;184(3):376-90. [Medline].
Barratt-Boyes BG, Simpson M, Neutze JM, et al. Intracardiac surgery in neonates and infants using deep hypothermia with surface cooling and limited cardiopulmonary bypass. Circulation. May 1971;43(5 Suppl):I25-30. [Medline].
Castaneda AR, Lamberti J, Sade RM, et al. Open-heart surgery during the first three months of life. J Thorac Cardiovasc Surg. Nov 1974;68(5):719-31. [Medline].
Fu YC, Bass J, Amin Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol. Jan 17 2006;47(2):319-25. [Medline].
Yip WC, Zimmerman F, Hijazi ZM. Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect. Catheter Cardiovasc Interv. Nov 2005;66(3):436-41. [Medline].
Predescu D, Chaturvedi RR, Friedberg MK, Benson LN, Ozawa A, Lee KJ. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg. Nov 2008;136(5):1223-8. [Medline].
Szkutnik M, Kusa J, Bialkowski J. Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience. Kardiol Pol. Sep 2008;66(9):941-7; discussion 948-9. [Medline].
| Syndrome | CCVM (%) | Type of CCVM |
| Del 4q, 21, 32 | 60 | Ventricular septal defect, atrial septal defect |
| Del 5p | 30-60 | Ventricular septal defect |
| Trisomy 13 | 80 | Atrial septal defect, ventricular septal defect, TOF |
| Trisomy 18, Edwards syndrome | 100 | Ventricular septal defect, TOF, double-outlet right ventricle (DORV) |
| Trisomy 21, Down syndrome | 40-50 | Ventricular septal defect, atrioventricular canal (AVC) |
| Del 22q11, DiGeorge syndrome (single gene etiology, autosomal dominant) | 50 | Truncus arteriosus, TOF, ventricular septal defect |

